These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9511073)

  • 1. Activity of quinupristin/dalfopristin against Staphylococcus epidermidis in biofilms: a comparison with ciprofloxacin.
    Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 1997 May; 39 Suppl A():103-8. PubMed ID: 9511073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
    Garcia R; Raad I
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):933-6. PubMed ID: 9031876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
    Sambatakou H; Giamarellos-Bourboulis EJ; Grecka P; Chryssouli Z; Giamarellou H
    J Antimicrob Chemother; 1998 Mar; 41(3):349-55. PubMed ID: 9578161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium.
    Hill RL; Smith CT; Seyed-Akhavani M; Casewell MW
    J Antimicrob Chemother; 1997 May; 39 Suppl A():23-8. PubMed ID: 9511058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Mocchegiani F; Silvestri C; Licci A; De Fusco M; Provinciali M; Saba V; Scalise G
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4042-5. PubMed ID: 16189078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates.
    Dowzicky M; Nadler HL; Feger C; Talbot G; Bompart F; Pease M
    Am J Med; 1998 May; 104(5A):34S-42S. PubMed ID: 9684656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.
    Tünger A; Aydemir S; Uluer S; Cilli F
    Indian J Med Res; 2004 Dec; 120(6):546-52. PubMed ID: 15654141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci.
    El-Azizi M; Rao S; Kanchanapoom T; Khardori N
    Ann Clin Microbiol Antimicrob; 2005 Jan; 4():2. PubMed ID: 15638934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin.
    Bouanchaud DH
    J Antimicrob Chemother; 1997 May; 39 Suppl A():15-21. PubMed ID: 9511057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro bactericidal activity of quinupristin/dalfopristin against adherent Staphylococcus aureus.
    Berthaud N; Desnottes JF
    J Antimicrob Chemother; 1997 May; 39 Suppl A():99-102. PubMed ID: 9511072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oxazolidinone, RBx 7644 (ranbezolid), on inhibition of staphylococcal adherence to plastic surfaces.
    Mathur T; Singhal S; Khan S; Bhateja P; Pandya M; Rattan A; Bhatnagar PK; Upadhyay DJ; Fatma T
    J Chemother; 2008 Aug; 20(4):420-7. PubMed ID: 18676219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
    Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y
    J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis.
    Mulazimoglu L; Drenning SD; Yu VL
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2428-30. PubMed ID: 8891159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid).
    Ling TK; Fung KS; Cheng AF
    Chemotherapy; 2001; 47(4):243-9. PubMed ID: 11399860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in-vitro activities of quinupristin-dalfopristin against Gram-positive bloodstream isolates.
    Schouten MA; Hoogkamp-Korstanje JA
    J Antimicrob Chemother; 1997 Aug; 40(2):213-9. PubMed ID: 9301986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Del Prete M; D'Amato G; Scalise G; Saba V
    Eur J Vasc Endovasc Surg; 2002 Sep; 24(3):230-4. PubMed ID: 12217284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus.
    Kang SL; Rybak MJ
    J Antimicrob Chemother; 1997 May; 39 Suppl A():33-9. PubMed ID: 9511060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between biofilms formed by Staphylococcus epidermidis and quinolones.
    Yassien M; Khardori N
    Diagn Microbiol Infect Dis; 2001 Jul; 40(3):79-89. PubMed ID: 11502373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis.
    Mouton JW; Endtz HP; den Hollander JG; van den Braak N; Verbrugh HA
    J Antimicrob Chemother; 1997 May; 39 Suppl A():75-80. PubMed ID: 9511068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.